Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M7,254Revenue $M3,118Net Margin (%)13.1Altman Z-Score4.5
Enterprise Value $M6,919EPS $4.1Operating Margin %17.2Piotroski F-Score7
P/E(ttm)18.2Beneish M-Score-2.4Pre-tax Margin (%)17.4Higher ROA y-yY
Price/Book4.510-y EBITDA Growth Rate %11.0Quick Ratio1.4Cash flow > EarningsY
Price/Sales2.45-y EBITDA Growth Rate %5.4Current Ratio1.8Lower Leverage y-yY
Price/Free Cash Flow19.9y-y EBITDA Growth Rate %2.6ROA % (ttm)11.5Higher Current Ratio y-yN
Dividend Yield %--PEG3.4ROE % (ttm)24.4Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M96.9ROIC % (ttm)31.5Gross Margin Increase y-yN

Gurus Latest Trades with VAR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VARJoel Greenblatt 2015-09-30 Add0.35%$71.44 - $90.39
($83.2)
$ 74.87-10%Add 5854.93%500,631
VARFirst Eagle Investment 2015-09-30 Buy 0.03%$71.44 - $90.39
($83.2)
$ 74.87-10%New holding153,130
VARCharles Brandes 2015-09-30 Add$71.44 - $90.39
($83.2)
$ 74.87-10%Add 2.03%135,215
VARJoel Greenblatt 2015-06-30 Reduce-0.06%$83.6 - $96.14
($89.35)
$ 74.87-16%Reduce -91.60%8,407
VARCharles Brandes 2015-06-30 Reduce$83.6 - $96.14
($89.35)
$ 74.87-16%Reduce -0.60%132,527
VARJoel Greenblatt 2015-03-31 Reduce-0.1%$84.86 - $94.91
($91.5)
$ 74.87-18%Reduce -57.64%100,133
VARCharles Brandes 2015-03-31 Reduce-0.02%$84.86 - $94.91
($91.5)
$ 74.87-18%Reduce -11.96%133,327
VARJoel Greenblatt 2014-12-31 Buy 0.17%$78.17 - $89.09
($85.04)
$ 74.87-12%New holding236,388
VARJoel Greenblatt 2014-09-30 Sold Out -0.09%$80.89 - $87.52
($84.12)
$ 74.87-11%Sold Out0
VARJoel Greenblatt 2014-06-30 Add0.05%$78.66 - $84.85
($81.92)
$ 74.87-9%Add 130.23%88,471
VARRobert Karr 2014-03-31 Sold Out -1.6%$77.34 - $84.96
($81.95)
$ 74.87-9%Sold Out0
VARRobert Karr 2013-09-30 Buy 1.7%$66.3 - $76.27
($72.25)
$ 74.874%New holding305,000
VARCharles Brandes 2013-09-30 Buy 0.12%$66.3 - $76.27
($72.25)
$ 74.874%New holding122,218
VARMario Gabelli 2013-06-30 Sold Out $64.02 - $72.78
($68.3)
$ 74.8710%Sold Out0
VARJoel Greenblatt 2013-03-31 Add0.07%$68.66 - $75.25
($72.28)
$ 74.874%Add 65.73%47,672
VARJoel Greenblatt 2012-12-31 Reduce-0.06%$57.08 - $72.35
($66.56)
$ 74.8712%Reduce -33.84%28,764
VARMario Gabelli 2012-12-31 Reduce$57.08 - $72.35
($66.56)
$ 74.8712%Reduce -30.95%5,355
VARJoel Greenblatt 2012-09-30 Add0.1%$53.73 - $61.76
($58.54)
$ 74.8728%Add 130.72%43,476
VARJoel Greenblatt 2012-06-30 Buy 0.08%$57.15 - $68.81
($63.01)
$ 74.8719%New holding18,844
VARJoel Greenblatt 2011-12-31 Sold Out -0.09%$50.1 - $67.13
($59.39)
$ 74.8726%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VAR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VAR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
WILSON DOW RPresident and CEO 2015-12-07Sell9,000$80-6.41view
ECKERT R ANDREWDirector 2015-12-02Sell3,000$81.67-8.33view
FINNEY ELISHA WExec VP and CFO 2015-11-24Sell2,334$80.9-7.45view
WILSON DOW RPresident and CEO 2015-11-06Sell18,000$80.26-6.72view
WILSON DOW RPresident and CEO 2015-09-08Sell9,000$80.05-6.47view
WILSON DOW RPresident and CEO 2015-08-06Sell9,000$86.67-13.61view
FINNEY ELISHA WExec VP and CFO 2015-08-03Sell2,000$85.96-12.9view
GUERTIN TIMOTHY EDirector 2015-08-03Sell4,000$85.57-12.5view
WILSON DOW RPresident and CEO 2015-07-06Sell9,000$85.8-12.74view
FINNEY ELISHA WExec VP and CFO 2015-07-02Sell2,000$85.95-12.89view

Quarterly/Annual Reports about VAR:

News about VAR:

Articles On GuruFocus.com
Wedgewood Partners Comments on Varian Medical Systems Jan 18 2016 
Wedgewood Partners 4th Quarter Client Letter: 'Back to Our Regularly Scheduled Stock Market' Jan 15 2016 
David Rolfe Trims Holdings in Alphabet, Visa in 3rd Quarter Nov 24 2015 
The Best Companies of the Medical Industry – September 2015 Sep 25 2015 
Wedgewood Partners 2nd Quarter 2015 Client Letter - Wedgewood On Sale Jul 20 2015 
Reversing a Declining Pattern in Earnings Per Share Feb 24 2015 
Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
No More a Simple Distributor Sep 07 2014 
Bearish Investor John Hussman's 5 Top New Stock Buys May 02 2014 
David Rolfe Comments on Varian Medical Systems Apr 18 2014 

More From Other Websites
VARIAN MEDICAL SYSTEMS INC Files SEC form 10-Q, Quarterly Report Feb 09 2016
Medical Appliances & Equipment Equities Ahead of Market -- ResMed, ZELTIQ Aesthetics, MiMedx Group,... Feb 03 2016
Varian Medical Systems, Inc. Earnings Analysis: Q1, 2016 By the Numbers Jan 29 2016
Varian (VAR) Beats Q1 Earnings and Revenue Estimates Jan 28 2016
Edited Transcript of VAR earnings conference call or presentation 27-Jan-16 10:00pm GMT Jan 28 2016
Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2016 Jan 27 2016
VARIAN MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 27 2016
Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2016 Jan 27 2016
Q1 2016 Varian Medical Systems Inc Earnings Release - After Market Close Jan 27 2016
Varian Medical Systems Appoints Dr. Patrick Kupelian VP of Clinical Affairs Jan 26 2016
Varian Medical Systems Appoints Dr. Patrick Kupelian VP of Clinical Affairs Jan 26 2016
Varian (VAR) Q1 Earnings Preview: A Surprise in Store? Jan 25 2016
Varian Honored Among World's 100 Most Sustainable Corporations for Second Year Running Jan 21 2016
Varian Honored Among World's 100 Most Sustainable Corporations for Second Year Running Jan 21 2016
Varian Medical Update: Why Barrington Likes 'Clear Market Leader' Jan 12 2016
Varian ProBeam Proton Therapy System First to Receive Saudi FDA Authorization Jan 11 2016
Varian ProBeam Proton Therapy System First to Receive Saudi FDA Authorization Jan 11 2016
Varian Medical Systems 2015 Annual Report Now Available on Investor Web Site Jan 07 2016
Varian Medical Systems 2015 Annual Report Now Available on Investor Web Site Jan 07 2016
Varian Medical Systems, Inc. – Value Analysis (NYSE:VAR) : January 5, 2016 Jan 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK